These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3503911)

  • 1. Nasal and conjunctival contributions to the systemic absorption of topical timolol in the pigmented rabbit: implications in the design of strategies to maximize the ratio of ocular to systemic absorption.
    Chang SC; Lee VH
    J Ocul Pharmacol; 1987; 3(2):159-69. PubMed ID: 3503911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic absorption pathways of topically applied beta adrenergic antagonists in the pigmented rabbit.
    Lee YH; Kompella UB; Lee VH
    Exp Eye Res; 1993 Sep; 57(3):341-9. PubMed ID: 7901046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative effectiveness of prodrug and viscous solution approaches in maximizing the ratio of ocular to systemic absorption of topically applied timolol.
    Chang SC; Chien DS; Bundgaard H; Lee VH
    Exp Eye Res; 1988 Jan; 46(1):59-69. PubMed ID: 3342834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine.
    Kyyrönen K; Urtti A
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1827-33. PubMed ID: 2211028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the ocular to systemic ratio of topical timolol by varying the dosing time.
    Ohdo S; Grass GM; Lee VH
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2790-8. PubMed ID: 1894477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose O-butyryl timolol improves the therapeutic index of timolol in the pigmented rabbit.
    Chang SC; Bundgaard H; Buur A; Lee VH
    Invest Ophthalmol Vis Sci; 1988 Apr; 29(4):626-9. PubMed ID: 3356517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basis for dosing time-dependent changes in the ocular and systemic absorption of topically applied timolol.
    Lee VH; Yamahara H; Gurny R; Sintzel MB; Martenet M; Gex-Fabry M; Balant L; Ohdo S; Podder SK
    J Ocul Pharmacol Ther; 1996; 12(2):103-13. PubMed ID: 8773926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration and long-term efficacy of phenylephrine-induced reduction in the systemic absorption of ophthalmic timolol in rabbits.
    Järvinen K; Urtti A
    J Ocul Pharmacol; 1992; 8(2):91-8. PubMed ID: 1506759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular drug interactions involving topically applied timolol in the pigmented rabbit.
    Luo AM; Sasaki H; Lee VH
    Curr Eye Res; 1991 Mar; 10(3):231-40. PubMed ID: 2044391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light-dark variations in ocular timolol concentrations following topical solution instillation in the pigmented rabbit.
    Ohdo S; Zhu J; Lee VH
    Life Sci; 1992; 51(26):2025-31. PubMed ID: 1474859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the safety of topically applied timolol in the pigmented rabbit through manipulation of formulation composition.
    Podder SK; Moy KC; Lee VH
    Exp Eye Res; 1992 May; 54(5):747-57. PubMed ID: 1623960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of epinephrine pretreatment and solution pH on ocular and systemic absorption of ocularly applied timolol in rabbits.
    Kyyrönen K; Urtti A
    J Pharm Sci; 1990 Aug; 79(8):688-91. PubMed ID: 2231330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of drug release rate on systemic timolol absorption from polymeric ocular inserts in the pigmented rabbit.
    Lee VH; Li SY; Sasaki H; Saettone MF; Chetoni P
    J Ocul Pharmacol; 1994; 10(2):421-9. PubMed ID: 8083561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic basis for nonadditivity of intraocular pressure lowering in timolol combinations.
    Lee VH; Luo AM; Li SY; Podder SK; Chang JS; Ohdo S; Grass GM
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2948-57. PubMed ID: 1917398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microemulsions as topical delivery vehicles: ocular administration of timolol.
    Gasco MR; Gallarate M; Trotta M; Bauchiero L; Gremmo E; Chiappero O
    J Pharm Biomed Anal; 1989; 7(4):433-9. PubMed ID: 2490750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular absorption, distribution, and systemic absorption of a novel antiglaucoma medication, prostaglandin derivative, in male white rabbits.
    Higaki K; Kamata K; Takeuchi M; Inazawa K; Chikai T; Hamaguchi T; Yukawa T; Kadono K; Kawahara S; Nakano M
    Drug Metab Dispos; 1995 Jan; 23(1):35-43. PubMed ID: 7720522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application site dependent ocular absorption of timolol.
    Urtti A; Sendo T; Pipkin JD; Rork G; Repta AJ
    J Ocul Pharmacol; 1988; 4(4):335-43. PubMed ID: 3246568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation influence on conjunctival penetration of four beta blockers in the pigmented rabbit: a comparison with corneal penetration.
    Ashton P; Podder SK; Lee VH
    Pharm Res; 1991 Sep; 8(9):1166-74. PubMed ID: 1788163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes.
    Chiang CH; Ho JI; Chen JL
    J Ocul Pharmacol Ther; 1996; 12(4):471-80. PubMed ID: 8951683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model to predict aqueous humor and plasma pharmacokinetics of ocularly applied drugs.
    Grass GM; Lee VH
    Invest Ophthalmol Vis Sci; 1993 Jun; 34(7):2251-9. PubMed ID: 8505206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.